EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Emergence of KPC-8-producing K. pneumoniae infection without prior exposure to ceftazidime/avibactam: the threat of de novo infections by ceftazidime/avibactam-resistant KPC variants

María Alejandra Mateo-Vargas iD, Salud Rodríguez-Pallares, Jorge Arca-Suárez, Lorena López-Cerero iD, Manuel Rodríguez-Iglesias, Fátima Galán-Sánchez iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.01494-24 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von María Alejandra Mateo-Vargas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Biomedicina, Biotecnología y Salud Pública, Universidad de Cádiz, Cadiz, Spain. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Azabicyclo Compounds, Bacterial Proteins, beta-Lactamases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Menarini Group (Menarini Ricerche SpA), Instituto de Salud Carlos III, Centro de Investigación Biotecnológica en Red de Enfermedades Infecciosas (CIBERINFEC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

De novo infections caused by ceftazidime/avibactam-resistant KPC variants are rarely reported. We characterize the evolution of a KPC-8-producing Klebsiella pneumoniae strain involved in a primary infection without previous ceftazidime/avibactam treatment. During a 15-month follow-up, changes in carbapenem susceptibility due to porin alterations were observed, remaining susceptible to meropenem/vaborbactam, imipenem/relebactam, and cefiderocol. High- and low-permeability recombinant Escherichia coli isolates analysis revealed that, unlike the widespread ceftazidime/avibactam-resistant variant KPC-31, KPC-8 confers ceftazidime/avibactam resistance without decreasing carbapenemase activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsAzabicyclo CompoundsBacterial Proteinsbeta-LactamasesCeftazidimeKlebsiella InfectionsKlebsiella pneumoniaeHumansMaleCarbapenemsCefiderocolCephalosporinsDrug CombinationsDrug Resistance, Multiple, BacterialEscherichia coliImipenemMeropenemMicrobial Sensitivity TestsAdultBoronic AcidsHeterocyclic Compounds, 1-Ring

Stichwörter der Autor:innen

KPC-31KPC-8Klebsiella pneumoniaeantimicrobial resistancecefiderocolceftazidime/avibactamevolutionimipenem/relebactammeropenem/vaborbactamβ-lactamase

Substanzen

Anti-Bacterial Agentsavibactam, ceftazidime drug combinationAzabicyclo CompoundsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsCefiderocolCeftazidimeCephalosporins

Autor:innen und Institutionen

  • Departamento de Biomedicina, Biotecnología y Salud Pública, Universidad de Cádiz, Cadiz, Spain.
  • Servicio de Microbiología and Instituto de Investigación Biomédica A Coruña (INIBIC), Complexo Hospitalario Universitario A Coruña, A Coruña (Spain), A Coruña, Spain.
  • CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Instituto de Biomedicina de Sevilla IBIS, Seville, Spain.
  • Departamento de Microbiología, Universidad de Sevilla, Seville, Spain.
  • Servicio de Microbiología and Instituto de Innovación e Investigación Biomédica de Cádiz (INIBICA), Hospital Universitario Puerta del Mar, Cadiz, Spain.

ORCID-Profile: María Alejandra Mateo-Vargas, Lorena López-Cerero, Fátima Galán-Sánchez

Förderung

  • Menarini Group (Menarini Ricerche SpA)
  • Instituto de Salud Carlos III
  • Centro de Investigación Biotecnológica en Red de Enfermedades Infecciosas (CIBERINFEC)
  • Axencia Galega de Innovación

Zitieren

APA

Mateo-Vargas, M. A., Rodríguez-Pallares, S., Arca-Suárez, J., López-Cerero, L., Rodríguez-Iglesias, M., & Galán-Sánchez, F. (2025). Emergence of KPC-8-producing K. pneumoniae infection without prior exposure to ceftazidime/avibactam: the threat of de novo infections by ceftazidime/avibactam-resistant KPC variants. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01494-24

Vancouver

Mateo-Vargas MA, Rodríguez-Pallares S, Arca-Suárez J, López-Cerero L, Rodríguez-Iglesias M, Galán-Sánchez F. Emergence of KPC-8-producing K. pneumoniae infection without prior exposure to ceftazidime/avibactam: the threat of de novo infections by ceftazidime/avibactam-resistant KPC variants. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01494-24

BibTeX
@article{MateoVargas2025,
  author = {Mateo-Vargas, María Alejandra and Rodríguez-Pallares, Salud and Arca-Suárez, Jorge and López-Cerero, Lorena and Rodríguez-Iglesias, Manuel and Galán-Sánchez, Fátima},
  title = {Emergence of KPC-8-producing K. pneumoniae infection without prior exposure to ceftazidime/avibactam: the threat of de novo infections by ceftazidime/avibactam-resistant KPC variants},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.01494-24}
}
Kostenlos starten →